ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,240.03
      1.04%
      US Tech 100
      17,481.60
      0.38%
      Dow Jones
      38,997.66
      0.76%
      Brent Oil
      76.00
      -0.03%
      Bitcoin
      55,981.47
      -0.12%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Quadrise Plc (QED) Quote

      Quadrise Plc

      Quadrise Plc (QED)

      IQ Hedge Event Driven Tracker ETF
      1.67
      -0.045
      (-2.62%)
      Closed August 06 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      1.67
      Bid
      1.545
      Ask
      1.795
      Volume
      1,272,407
      0.00 Day's Range 0.00
      0.66 52 Week Range 3.30
      Market Cap
      29.471M
      Previous Close
      1.715
      Open
      -
      Last Trade
      40000
      @
      1.685
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      3,849,323
      Shares Outstanding
      1,764,714,550
      Dividend Yield
      -
      PE Ratio
      -9.50
      Earnings Per Share (EPS)
      -0
      Revenue
      -
      Net Profit
      -3.09M

      About Quadrise Plc

      Sector
      Crude Petroleum & Natural Gs
      Industry
      Investment Advice
      Website
      www.quadrisefuels.com
      Headquarters
      London, Gbr
      Founded
      2006
      Quadrise Plc is listed in the Crude Petroleum & Natural Gs sector of the London Stock Exchange with ticker QED. The last closing price for Quadrise was 1.72p. Over the last year, Quadrise shares have traded in a share price range of 0.66p to 3.30p.

      Quadrise currently has 1,764,714,550 shares outstanding. The market capitalization of Quadrise is £30.26 million. Quadrise has a price to earnings ratio (PE ratio) of -9.50.

      QED Latest News

      More News

      Cyclo Therapeutics Announces Notice of Decision to Grant European Patent Application for Treatment of Alzheimer’s Disease from European Patent Office

      Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and...

      July 29 2024
      Business Wire

      Form 8-K - Current report

      July 17 2024
      Edgar (US Regulatory)

      Cyclo Therapeutics to Present at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium 2024

      Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and...

      June 25 2024
      Business Wire

      Rafael Holdings Reports Third Quarter Fiscal 2024 Financial Results

      NEWARK, N.J., June 14, 2024 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the third quarter and the first nine months of fiscal 2024 ended April...

      June 14 2024
      GlobeNewswire Inc.

      Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1

      TransportNPC™ is the most comprehensive ongoing controlled pivotal study regarding patient size, global footprint, duration and clinical outcomes for the treatment of Niemann-Pick Disease Type C1...

      May 30 2024
      Business Wire

      Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

      Ongoing progress toward last patient enrolled in pivotal Phase 3 study (“TransportNPC™”) evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1), expected Q2 2024...

      May 16 2024
      Business Wire

      Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update

      Continued progress of pivotal Phase 3 study (TransportNPC™) evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) toward 48-week comparative interim analysis data...

      March 18 2024
      Business Wire

      Cyclo Therapeutics Announces Issuance of U.S. Patent Covering the Use of Trappsol® Cyclo™ for the Treatment of Alzheimer’s Disease

      Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and...

      March 14 2024
      Business Wire

      Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results

      Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a...

      March 13 2024
      GlobeNewswire Inc.

      Form 8-K/A - Current report: [Amend]

      March 04 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0754.702194357371.5951.8051.59543461841.69245365DE
      4-0.33-16.522.051.5628270031.78134868DE
      120.247517.39894551851.42252.51.438493231.99723777DE
      26-1.13-40.35714285712.82.81.1550167791.78270486DE
      520.4739.16666666671.23.30.6652015831.76977873DE
      156-1.29-43.58108108112.9650.6642513411.86552526DE
      260-2.205-56.90322580653.8756.660.6639735472.33211392DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      CGHChaarat Gold Holdings Ltd
      0.225p
      (80.72%)
      		67.73M
      DESTDestiny Pharma Plc
      5.25p
      (23.53%)
      		4.23M
      EPPEnergypathways Plc
      2.10p
      (23.53%)
      		10.88M
      VRSVersarien Plc
      0.088p
      (20.55%)
      		257.75M
      BMNBushveld Minerals Limited
      0.625p
      (19.05%)
      		1.16M
      ORCHOrchard Funding Group Plc
      21.50p
      (-32.81%)
      		259.7k
      GILDGuild Esports Plc
      0.155p
      (-27.57%)
      		68.92M
      TM1Technology Minerals Plc
      0.175p
      (-22.22%)
      		30.82M
      MOREHostmore Plc
      12.00p
      (-20.40%)
      		685.24k
      EXREngage Xr Holdings Plc
      0.95p
      (-17.39%)
      		3.85M
      ECHOEcho Energy Plc
      0.0033p
      (-10.81%)
      		2.75B
      MSMNMosman Oil And Gas Limited
      0.064p
      (18.52%)
      		1.25B
      UKOGUk Oil & Gas Plc
      0.0565p
      (-10.32%)
      		1.12B
      TRPTower Resources Plc
      0.0145p
      (7.41%)
      		369.71M
      WBIWoodbois Limited
      0.36p
      (14.29%)
      		293.8M

      Discussion

      View Full Feed
      janice shell janice shell 6 minutes ago
      We are aware there hasn't been a president you liked since Calvin Coolidge.
      zooey zooey 6 minutes ago
      Not a single compliment in the post, bro..
      SFRX
      TooYoungToDie TooYoungToDie 6 minutes ago
      30 billion OS only, could see a dimension fast, lol
      PHIL
      PROPHET-of-PROFITS PROPHET-of-PROFITS 6 minutes ago
      Poker tell when the large 6 bid moves to 7
      IDVV
      m$teamworkotc m$teamworkotc 7 minutes ago
      aqua others----did you read latest filing? it appears JIM got the 50k needed for toxicity study....RIGHT?
      GSTC
      mascale mascale 7 minutes ago
      Anyone literate does not regard profitable operations gutter-lowlife!
      HIRU
      janice shell janice shell 7 minutes ago
      Pretty amazing!
      Nsnz33 Nsnz33 8 minutes ago
      Wouldn’t we know if he did? Or do you mean he might be using proxies to circumvent the “you can’t buy if you’re an insider” rule if there is indeed some JV or other deal in the works behind the scenes?
      FFMGF
      Jackrabbitslim Jackrabbitslim 8 minutes ago
      Ron is not answering emails. I guess he is to busy over at his Alchemy fund job.
      GNCP
      Chinese Ryder Chinese Ryder 8 minutes ago
      Career criminal that needs to be locked up.
      INTK
      4retire 4retire 8 minutes ago
      What? Employees buying 40% under market, please explain which companies are doing this. I know in some private placements, the offering is made at substantial discounts (normally OTC stocks).
      NVDA
      m$teamworkotc m$teamworkotc 8 minutes ago
      its lucky to be trading 0036-004 ...it should be 002 max....its a Chinese SCAM....but hey the name change will change everything lol
      DWYER and MCLAIN thank us all
      IGPK
      m$teamworkotc m$teamworkotc 10 minutes ago
      10b Saudi fraud....
      fortune 500 reveal
      bonuses in the 10s of millions while shareholders got reamed.
      AULT a 10% owner getting mafia like deals from his partner
      etc etc etc

      BTW>>>DID MULN IPO UNDER THE PREMISE OF SELLING REBRANDED CHINESE JUNK?
      wheres
      AULT MULN
      mascale mascale 10 minutes ago
      Regarding profitable operations off-topic: Gutter lowlife posting, noted.
      HIRU
      Drugdoctor Drugdoctor 11 minutes ago
      It says there are new posts on the board, but I show no new post. Iggy bus must have pulled up to the station, lmao
      FORW
      PENNIEStoSTACKS PENNIEStoSTACKS 11 minutes ago
      https://x.com/PENNIEStoSTACKS/status/1820963644269817860
      ASII
      Starlost Starlost 11 minutes ago
      Same old cut and paste for years....boring.
      GIFX
      PROPHET-of-PROFITS PROPHET-of-PROFITS 12 minutes ago
      Nice job following their progress. Five star
      IDVV
      Chromosome Chromosome 13 minutes ago
      With 4.6 million in R&D expenses in just the last quarter (say 20 mn annualized), you have to think there is something up their sleeves as far as new formulation. Not much D going on so mostly R. The question is if they come up with a new formulation, can they bi-pass a fully clinical trial. A PK/PD
      AMRN
      NorthShoreTrading NorthShoreTrading 14 minutes ago
      August 15th launch date, then NFL season begins 2 weeks after that!
      IDVV
      JimmyCrickets JimmyCrickets 14 minutes ago
      That makes 3 posting here! This reminds of a stock I had in the past that had only a few posters. price went up a little and then one day about 20 new posters showed up and without any news it went up about 3000%. I hope this is like that one.
      IHGP
      Just the facts maam Just the facts maam 14 minutes ago
      I think whatever is going on with ANIP includes a yet to be announced move of their Headquarters

      In their FAQ'
      WHERE IS ANI PHARMACEUTICALS LOCATED?
      ANI has four locations including two U.S.-based manufacturing facilities and a facility in India. Our headquarters is
      ANIP

      Your Recent History

      LSE
      QED
      Quadrise
      Delayed Upgrade Clock